National Cancer Conference
- American Cancer Society Experts Present Key Research at 2022 ASCO Meeting May 23, 2022
- American Cancer Society’s Impact Venture Capital Fund Releases Performance Results to Date May 19, 2022BrightEdge Impact Venture Capital Fund Reports Net Asset Value of Some $77 Million
- New Study Finds Medicaid Expansion Increases Survival, Reduces Health Disparities for Newly Diagnosed Patients with Cancer May 18, 2022American Cancer Society researchers report findings suggest better access to timely and effective treatments
- New Study Reports Need to Monitor Public Interest in Shopping and Sales of Popular Puff Bar E-cigarette Brand May 12, 2022American Cancer Society researchers stress health interventions to continue reducing e-cigarette use among youth
- Collaboration Between Leading Health Organizations Aims to Improve Health Outcomes in Communities of Color May 6, 2022Bank of America Convenes the American Heart Association®, American Diabetes Association®, American Cancer Society and the University of Michigan School of Public Health for an Innovative Initiative to Improve Health and Health Care Across the U.S.
- Published on Oct 13, 2016
Robert Andtbacka, MD, CM of the Huntsman Cancer Institute, Salt Lake City, UT discusses the use of oncolytic viruses at the 2016 World Congress on Cancers of the Skin (WCCS) and the Congress of the European Association of Dermato-Oncology (EADO) in Vienna, Austria.
Health Care Forum “War on Cancer” (March 30th 2017-Singapore)
Related ArticlesOncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferondependent antiviral defense - Research Article (Biomed Central)
Childhood virus RSV shows promise against adult cancer. - Science Daily
CZ BioMed licenses children’s virus turned anti-cancer agent. - San Antonio Business Journal
Category Archives: Colon Cancer
Kocal Consulting Corporation Celebrates new Consulting Agreement with CZ Biomed Corp to Help Deliver Real Value to Bio-pharmaceutical World Bio-pharmaceutical insiders have long known about the important, diverse work being done by CZ Biomed Corp, some of which could have … Continue reading
Oncolytic Virus “Respiratory Syncytial Virus” (RSV) Genetically Engineered to Treat Various Cancers Shows Stunning Results in Treating Colon Cancer Press Release – November 11, 2015 CZ BioMed Corp. Announces 2.5 Year Survival of Stage 4 Colon Cancer Patient. Cancer Free … Continue reading